Search results
Novavax (NVAX) Seeks FDA Nod for Updated COVID-19 Vaccine
Zacks via Yahoo Finance· 2 days agoNovavax (NVAX) seeks FDA???s approval to update its COVID-19 vaccine for the 2024-2025 fall season...
Moderna's (MRNA) Next-Gen COVID-19 Jab Study Meets Efficacy Goal
Zacks via Yahoo Finance· 4 days agoData from a late-stage study shows that Moderna's (MRNA) next-generation COVID-19 vaccine achieved...
...Clinical Study Evaluating the Company's Next-Generation COVID-19 Vaccine Candidate, GEO-CM04S1
NewMediaWire via Yahoo Finance· 1 day ago10,000-participant randomized Phase 2b study will evaluate and compare GeoVax's multi-antigen, ...
KP.3 is the dominant COVID-19 variant in the US: Latest on test positivity, deaths, symptoms
USA Today· 6 days agoCases of the latest COVID-19 variant, also known as KP.3, are on the rise in the United States....
New COVID-19 strain KP.3 circulating in US. What is the situation in Riverside County?
The Desert Sun· 4 days agoA new COVID-19 variant called KP.3 is on the rise in the United States and has been detected in...
Pfizer Invites Public to View and Listen to Webcast of July 30 Conference Call with Analysts
Morningstar· 24 hours agoPfizer Inc. (NYSE: PFE) invites investors and the general public to view and listen to a webcast of a conference call with investment analysts at 10:30 a.m. EDT on Tuesday ...
We Won't Solve Long COVID Until We Decide What It Is
Medscape· 1 day agoIs a slow recovery from COVID-19 the lingering effects of a bad infection or the start of a new syndrome?
Pfizer Provides Update on Phase 3 Study of Investigational Gene Therapy for Ambulatory Boys with...
Morningstar· 7 days agoPfizer Inc. (NYSE: PFE) today announced that CIFFREO, a Phase 3 global, multicenter, randomized, double-blind, placebo-controlled study evaluating the investigational ...